Global

Diabetes & Endocrinology Experts

Xiaodong Cheng

Professor and Chairman
Department of Patient Care
Unit Bolzano Regional Hospital
Austria

Biography

Dr. Cheng is a Professor in the Department of Pharmacology and Toxicology at the University of Texas Medical Branch and Deputy Director of the NIEHS funded Center in Environmental Toxicology at UTMB. He is also a member of the Sealy Center of Cancer Cell Biology Sealy Center of Structural Biology and Molecular Biophysics and Center for Addiction Research. He received his PhD in Biochemistry and Molecular Biology at the University of Texas Medical Branch in 1994 and completed a postdoctoral fellowship in biochemistry under Professor Susan Taylor from University of California in San Diego in 1999. Dr. Cheng is a recipient of an American Cancer Society Research Scholar Award. He has also received the HUPO 3rd World Congress Young Scientist Award in 2004. Dr. Cheng currently serves as an Editor for Acta Biochimica et Biophysica Sinica and is on the Editorial Boards of Frontiers in Bioscience and The Open Proteomics Journal. Dr. Cheng is a Professor in the Department of Pharmacology and Toxicology at the University of Texas Medical Branch and Deputy Director of the NIEHS funded Center in Environmental Toxicology at UTMB. He is also a member of the Sealy Center of Cancer Cell Biology Sealy Center of Structural Biology and Molecular Biophysics and Center for Addiction Research. He received his PhD in Biochemistry and Molecular Biology at the University of Texas Medical Branch in 1994 and completed a postdoctoral fellowship in biochemistry under Professor Susan Taylor from University of California in San Diego in 1999. Dr. Cheng is a recipient of an American Cancer Society Research Scholar Award. He has also received the HUPO 3rd World Congress Young Scientist Award in 2004. Dr. Cheng currently serves as an Editor for Acta Biochimica et Biophysica Sinica and is on the Editorial Boards of Frontiers in Bioscience and The Open Proteomics Journal.

Research Interest

Dr. Cheng\\\\\\\'s research program focuses on using multidisciplinary approaches, coupling biochemistry and biophysics with cell biology and pharmacology, to understand the structure and function of exchange protein directly activated by cAMP (Epac) and oncogene KRAS. Our long-term goals are to unravel the signaling intricacies of Epac and KRAS and to design pathway specific inhibitors for these important signaling molecules so that their functions can be pharmaceutically exploited and modulated for the treatment of human diseases.

Global Experts from Austria

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America